IHH Healthcare's Pantai Hospital Kuala Lumpur has achieved a cardiovascular care milestone with the successful completion of the first Iberis® renal denervation (RDN) transradial procedure across the Pantai Hospitals Group.

The achievement marks an important step forward in expanding treatment options for patients with uncontrolled or resistant hypertension, a condition that can increase the risk of serious cardiovascular complications if left unmanaged.
Renal denervation is a minimally invasive procedure designed to help lower blood pressure by targeting nerves surrounding the renal arteries. For suitable patients whose blood pressure remains difficult to control despite medication and lifestyle interventions, the procedure may offer an additional treatment option to support improved long-term cardiovascular health.
The Iberis® RDN System supports both transradial and transfemoral approaches, providing clinicians with greater flexibility when tailoring treatment to individual patient needs. The transradial approach, performed through the wrist, represents another advancement in the evolution of minimally invasive cardiovascular procedures.
The milestone reflects Pantai Hospital Kuala Lumpur's commitment to advancing cardiovascular care through innovation and the adoption of new treatment technologies. It also highlights ongoing efforts across the IHH network to expand access to advanced therapies and improve outcomes for patients with complex cardiovascular conditions.
As healthcare continues to evolve, innovations such as renal denervation are creating new possibilities for managing chronic conditions and supporting better long-term health outcomes.